main_logo
PMG
End-to-end expertise informs every point on the product pathway

more
PVH
Establishing clinical, economic and humanistic value to open the gateway to access

more
OVERVIEW
AI
ACCESS

Discover the Power
of Your Data

Multiomics
Harmonized. Visualized. AI-informed.

REQUEST A DEMO

Discover the Power of Your Data

Multiomics
Harmonized. Visualized. AI-informed.

REQUEST A DEMO

Discover the Power of Your Data

Multiomics
Harmonized. Visualized. AI-informed.

REQUEST A DEMO

QuartzBio Announces Addition of Artificial Intelligence-Based Signature Development

QuartzBio™ now delivers an end-to-end solution for disease mechanism understanding, drug target discovery, biomarker identification, patient stratification, and drug repositioning.

READ MORE

Access Complete Multiomic Data in Real-Time

Clinical/EDC

Flow Cytometry

Genomics

IHC/Imaging

Proteomics

Transcriptomics

Access complete biomarker data in real-time, impact on-trial decision making and cross trial comparisons.

Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies novel biomarker approaches to clinical research leveraging the latest advancements in science and technology. The Precison for Medicine QuartzBio multiomic data integration and informatics platform enables life sciences companies to discover hidden subgroups of patients who will most benefit from a given therapy, delivering the means for truly personalized medicine. Precision for Medicine is part of Precision Medicine Group, with over 1,800 employees in 30 locations in the US, Canada, and Europe.

© 2019 Precision Medicine Group, LLC. All rights reserved